Compare Levi Strauss & Co. (LEVI) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Levi Strauss & Co. vs TransMedics Group Inc — how do they compare? Levi Strauss & Co. trades at $22.73 (market cap $8.75B), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: Levi Strauss & Co. is far larger — about 2.8× TransMedics Group Inc's market cap, and Levi Strauss & Co. pays a 2.81% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| LEVI | TMDX | |
|---|---|---|
Market Cap | $8.75B | $3.10B |
Sector | Consumer Cyclical | Technology |
52-Week High | $25.53 | $150.42 |
52-Week Low | $17.92 | $61.99 |
Enterprise Value | $10.07B | $3.49B |
Dividend Yield | 2.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Levi Strauss & Co.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
